Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: ChinuSFO who wrote (11181)	7/10/1998 9:02:00 PM
From: VLAD	Respond to of 23519

CR, How about we discuss a buy-out with a corporate giant? How about we discuss what a fair price is currently for a buy-out. If it occurs I believe it will occur in the form of a stock swap which certainly would allow a premium over cash. I think there are but only 2 likely candidates which are the giants they have been dealing with all along--Astra and J&J. I would rather own J&J over Astra stock. Vivus does have one thing in their favor regarding the buy-out and that is whoever buys them gets the US and Japan on top of their already established international territory. Also, the buyer becomes the supplier of MUSE to the other company. Another even better possibility would be a joint buy-out by both companies. This would create less commitment by one company alone. One can have the US and the other can have Japan and then they can jointly pay the costs of manufacturing and share rights to the IU method.